Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Chronic Obstructive Pulmonary Disease
Clinical trial register · United States · industry-sponsored

Chronic Obstructive Pulmonary Disease Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9141 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 18 Oct 2026, 03:16 UTC
9141
Studies in scope
industry-sponsored, all four open statuses
4966
Recruiting now
open to new participants
2196
Lead sponsors
across recruiting studies
Top states
Florida 9 California 8 Illinois 6 Alabama 5 Georgia 5
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Chronic Obstructive Pulmonary Disease trials in the USA

11 of 9141 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Sanofi
Phase 3
1,508
California, Florida
2026-09-16
Recruiting
Nuvaira, Inc.
Not applicable
200
Alabama, Florida, Michigan, North Carolina, Ohio, Pennsylvania, Virginia, Wisconsin
2026-02-24
Recruiting
Sanofi
Phase 4
218
Alabama, Florida, Georgia, Kansas, Maryland, Massachusetts, North Carolina, Pennsylvania
2025-09-22
Recruiting
Sanofi
Phase 3
942
Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois
2025-09-17
Recruiting
Sanofi
Phase 3
942
Arizona, California, Florida, Georgia, Illinois, Indiana, Kansas, Louisiana
2025-09-16
Active, closed
Upstream Bio Inc.
Phase 2
666
California, Florida, Georgia, Illinois, Maryland, Minnesota, North Carolina, South Carolina
2025-07-02
Recruiting
Bambusa Therapeutics
Phase 1
286
Kentucky, New York
2025-05-08
Recruiting
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
NCT06603246Non-cystic Fibrosis Bronchiectasis, Chronic Obstructive Pulmonary Disease
Genentech, Inc.
Phase 1
128
Alabama, California, Kansas, North Carolina, Pennsylvania, Texas
2024-11-18
Active, closed
Areteia Therapeutics
Phase 2
30
Arkansas, California, Florida, Illinois, Indiana, Iowa, Maryland, Michigan
2024-07-09
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Alabama, Arizona, California, Florida, Georgia, Illinois, Indiana, Louisiana
2023-06-28
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
California, Colorado, Florida, Illinois, Iowa, Kansas, Kentucky, Michigan
2023-03-16
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-usa/condition/chronic-obstructive-pulmonary-disease

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,141 studies in total at the last sync on 18 Oct 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Chronic Obstructive Pulmonary Disease.

How many Chronic Obstructive Pulmonary Disease trials are recruiting in the US?

7 of the 11 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chronic Obstructive Pulmonary Disease), 11 studies
PhaseStudiesRecruitingShare
Phase 34336.4%
Phase 23027.3%
Phase 12218.2%
Not applicable119.1%
Phase 4119.1%

Most active sponsors

Lead sponsors with the most studies (Chronic Obstructive Pulmonary Disease)
Lead sponsorStudiesRecruiting
Sanofi44
Areteia Therapeutics10
Bambusa Therapeutics11
Genentech, Inc.11
Hoffmann-La Roche10
Merck Sharp & Dohme LLC10
Nuvaira, Inc.11
Upstream Bio Inc.10

Top states

Top states (Chronic Obstructive Pulmonary Disease), by number of studies with a site there
StateStudies
Florida9
California8
Illinois6
Alabama5
Georgia5
Kansas4
North Carolina4
Arizona3
Indiana3
Maryland3
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.